Lung cancer remains the most frequently diagnosed malignancy and the leading cause of cancer tumour-related mortality ...
Jacobio Pharmaceuticals Group Co., Ltd. ( ($HK:1167) ) just unveiled an update. Jacobio Pharmaceuticals Group Co., Ltd. announced that its ...
Monte Rosa Therapeutics is transitioning from an oncology focus to a next-gen immunology & inflammation platform. Read why ...
Background Hereditary haemorrhagic telangiectasia (HHT) and juvenile polyposis syndrome (JPS) can be caused by SMAD4 pathogenic variants. SMAD4 is a common transcription factor of the BMP/TGFβ ...
For example, naïve T cells increase in size before undergoing a burst of proliferation, while liver and fat cells enlarge or contract in response to nutrient availability. In these cases, size changes ...
Mapping transcription factor (TF) binding sites across the genome is key to understanding how cells control gene expression, yet pinpointing their footprints across the genome—especially in single ...
Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment essential. While chemotherapy and targeted drugs have ...
This model illustrates how SETD1B promotes the expansion of H3K4me3 epigenetic marks and upregulates MYC expression, driving cytokine-independent cell growth in FLT3-mutated AML. Acute myeloid ...
Researchers found that altering key enzymes involved in redox balance could disrupt the metabolism of Myc-driven lymphomas, which offers a potential new strategy to treat aggressive cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback